bioAffinity Technologies announces 1-for-15 reverse stock split to regain Nasdaq compliance

bioAffinity Technologies, Inc.

Reverse split effective at open of trading on Aug 24, 2026; every 15 shares become 1 share of BIAF.
Post-split shares outstanding ~592,373; new CUSIP 09076W406.
Split aims to meet Nasdaq minimum bid price requirement; no change to authorized shares or par value.
Proportionate adjustments made to outstanding stock options, RSUs, and warrants; fractional shareholders get cash.
Stockholders of record receive transfer agent notice; trading symbol remains BIAF.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.